Mental wellness startup Lissun targets phygital presence in over 25 cities this year

The centres will be located in Tier I and Tier II cities

Clinikk launches Family Physician's course to mark World Family Doctor Day on May 19

The curriculum has been curated for General Physicians working in Clinikk

Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India

Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia

BDR Pharma receives Rs. 685 crore of PE investment

Multiples is the first private equity (PE) investor in the company

Eight Roads announce US $ 250 million healthcare fund for India

This new fund is amongst the largest for the sector in India

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI

Moderna announces advancements in mRNA platform science for application across multiple diseases

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery

Adroit BioMed launches Fortisil range of skincare products

Bharat Rubber Works to exhibit at PharmaPack Europe 2022

Pharmapack offers the platform that enables Bharat Rubber Works to convey its story while simultaneously demonstrating the extraordinary advancements by the company in the field of pharmaceutical packaging

GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia

They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights